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ABSTRACT 
 
 
The anterior cruciate ligament (ACL) is the most frequently ruptured ligament, 
accounting for an estimated 200,000 injuries and approximately 100,000 reconstructive 
surgeries each year in the United States. Due to the poor regenerative potential of the 
ACL and limitations of current ACL reconstruction techniques, development of a tissue 
engineered graft could have a significant clinical impact. Despite the robust and versatile 
properties of synthetic scaffolds, current iterations still have high failure rates due to 
degradation, wear, or fatigue. Polyurethanes utilizing ester-based soft segments were 
recently investigated as potential ligament grafts due to their established 
biocompatibility, excellent mechanical properties, and exceptionally tunable structure. 
However, non-specific hydrolytic degradation makes it difficult to match tissue 
regeneration, resulting in premature graft failure or stress shielding of the neotissue. In 
contrast, a biomaterial that features system-responsive degradation would integrate with 
native ligament remodeling and thus provide effective load transfer. It is well 
established that a graded load transfer from the graft to the neotissue during remodeling 
is necessary for proper organization of connective tissues which is strongly correlated to 
the resulting mechanical properties. 
In this study, synthetic routes were first developed to create a linear polyurea 
elastomer system with appropriate chemistry to readily incorporate a biodegradable 
peptide diamine. Polyureas were selected due to their tunable segmental chemistry, high 
elasticity and fatigue strength, and mild reaction conditions that permits incorporation of 
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biological molecules at ambient conditions. Collagen-mimetic soft segments were first 
created by conjugating an enzyme-labile peptide diamine and commercially available 
polyether diamines. Candidate prepolymers were then chain extended with 
hexamethylene diisocyanate and mixed diamines. Particular focus was given to 
identifying compositions that permitted high molecular weight generation without 
gelation. By varying soft segment chemistry, soft segment molecular weight, and the 
hard-to-soft segment ratio, a library of polyureas was developed. This library was then 
used to elucidate key structure-property relationships necessary to tune mechanical 
properties and degradation rates of candidate polyureas. Finally, the enzyme-mediated 
degradation of candidate polyureas with variable peptide concentrations was 
investigated. In summary, synthesis of a novel biomaterial that combines the strength 
and tunability of synthetic elastomers with cell-responsive degradation will assist in the 
development of an improved tissue engineered graft for ACL reconstruction. 
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CHAPTER I 
INTRODUCTION  
 
1.1 Overview 
 
Physical activity requires the cooperation of numerous specialized 
musculoskeletal tissues including muscle, bone, ligament, and tendon. Musculoskeletal 
tissue injury and disease can have an enormous impact on quality of life and results in 
billions of dollars in medical costs. The anterior cruciate ligament (ACL) is the most 
commonly ruptured ligament with over 200,000 injuries and 100,000 surgeries every 
year. Direct medical costs from surgical repair are estimated to be over five billion 
dollars.
1-3 
The ACL is the major intra-articular ligament of the knee that connects the 
posterior-lateral part of the femur to the anterior-medial part of the tibia. It provides 
necessary joint stability and prevents excessive anterior translation of the femur that 
could result in dislocation, bone fracture, or cartilage damage.
4
 Damage to the ACL can 
result in pain, loss of mobility, joint instability, and often leads to injury of other tissues 
and the development of degenerative joint diseases, such as osteoarthritis.
5,6
 After 
rupture, angiogenesis does not occur within the ACL for approximately 12 weeks.
7
 As a 
result, damaged ACL tissue lacks significant vasculature and must depend on synovial 
fluid, contained within the joint capsule, for nutrient and waste transport. This 
inhibits natural regeneration and the result is often the need for surgical intervention.
5,8,9
 
The intrinsic properties of ACL-derived cells also play a role in its inadequate healing 
capacity.
10-14
 ACL fibroblasts exhibit inferior proliferation, migration, and responses to 
 2 
 
  
growth factors than fibroblast derived from the medial collateral ligament (MCL), and in 
response to injury, as well as demonstrate limited growth factor expression and lower 
upregulation of collagen type III, which has been shown to facilitate scar tissue 
formation.
10-15
 Despite the large number of ligament reconstructions performed each 
year, an ideal grafting material has yet to be developed.
5,9
 Current available 
reconstruction techniques for ACL repair include transplantation of autologous grafts, 
allogeneic grafts, and synthetic grafts.
2,16
  
 
1.2  Current Ligament Reconstruction 
1.2.1 Autografts 
Despite inherent limitations, the use of tendon autografts has been recognized as 
the “gold standard” of ACL repair.17-19 Autografts are typically harvested from the inner 
third of the patellar tendon or hamstring tendons and provide good mechanical strength 
as well as promote cell proliferation and differentiation
19-22
  
The bone-patellar-bone graft incorporates bony blocks from the harvest site that 
allow for rigid fixation and reduce the chance of tendon creep
21,23,24
 However, a large 
donor site incision and morbidity can lead to further complications such as harvest site 
pain, tendonitis, muscle atrophy.
24
 The hamstring tendon graft has gained popularity 
over recent years due to reduced donor site morbidity and smaller incision size compared 
to patellar tendon grafts. The hamstring graft is harvested by removing the 
semitendinosus and gracilis tendons that are then folded in half and combined to make a 
quadruple-strand tendon graft.  
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The hamstring graft is a more comparable with the native intact ACL and the 
multiple strand graft may act as an analog to the two-bundle structure of the native ACL. 
Disadvantages of the hamstring tendon graft include donor site morbidity, tendon creep, 
and slow tendon healing due to the lack of a rigid fixation system. 
22,25
 The quadriceps 
tendon is less commonly used but allows for a larger fibrous portion that has the 
potential to increase mechanical properties. A bony plug for rigid fixation at one end 
also provides a potential for greater mechanical properties but size and location of the 
donor site scar along with donor site morbidity pose as serious disadvantages.
26
 With all 
autografts, the donor site morbidity and limited availability are areas of concern that 
have given rise into investigation for a more suitable replacement.
26,27
 During 
reconstructive surgery, the surgeon harvests a portion of the patient’s patellar, hamstring, 
or quadriceps tendon to serve as a replacement ligament.
28,29
  
A graft taken from the patellar tendon typically utilizes the middle third of the 
tendon, and is explanted with a piece of bone from the patella. This is combined with 
another piece of bone from the insertion point at the tibia.
4
 A hole is then drilled through 
the tibia, where this “bone-patellar-bone” graft is inserted, stretched across the knee, and 
attached through another hole drilled into the femur. The “bone-patellar-bone” graft has 
high initial graft strength, and because it has a bone plug on each end, it can incorporate 
quickly with either fixation site. This allows for earlier motion of the knee and a shorter 
period of rehabilitation.
30
  
In general, autografts typically possess good initial mechanical strength and 
promote cell proliferation, and they are conducive to graft remodeling and integration 
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into the joint.
19,30-32
 Despite these advantages, the use of autogenous grafts is limited. 
Their long-term success is dependent on revascularization of the transplanted tissue, 
which is progressively surrounded by the synovial membrane.
7,33
 The availability of 
autogenous grafts can be an issue, whether due to the need for multiple surgeries or 
age.
29,34
 Finally, donor site pain, muscle atrophy, and tendonitis can lead to prolonged 
rehabilitation periods and can restrict patients from achieving pre-injury levels of 
activity.
35
 
 
1.2.2 Allografts 
Allografts typically use tendon grafts that have been harvested from cadavers and 
sterilized.
25
 The use of allografts eliminates the need for a second surgical site and donor 
site morbidity.
22
 Typical grafts are taken from the bone-patellar tendon or the Achilles 
tendon.
36,37
 Allografts are more readily available than autografts and are incorporated 
into the body much like autografts but at a slower rate.
22
 Disease transmission and 
bacterial infection have been a concern with the use of allografts. The chance of disease 
transmission from allografts is limited by harvesting grafts in sterile conditions, the use 
of a sterilization agent, and freezing the grafts until use.
22,38
 However, sterilization 
methods such as ethylene oxide and gamma radiation can negatively impact the 
mechanical properties of the graft. 
38
 Ethylene oxide gas leaves behind the toxic residues 
ethylene glycol and ethylene chlorohydrins that cause synovitis and dissolution of the 
graft. Gamma radiation is used to eliminate bacteria and viruses from the donor tissue. 
Radiation levels between 1 and 2 Mrad eliminate bacterial threats but radiation levels on 
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the order of 4 Mrad radiation are required to eliminate viruses. However, above 3 Mrad 
has been to shown to alter the mechanical properties of the graft and change the tissue 
morphology.
22,36
 Dry freezing and cryofreezing bypass the sterilization process and 
retain the grafts original mechanical properties.
39
 However, the chance of disease 
transmission and bacterial infection remains of concern. 
To circumvent problems associated with autogeneic tendon grafts, the use of 
allografts has been employed for ACL repair. Allografts are tissues harvested from a 
cadaver, such as the patellar, hamstring, and achilles tendon, which eliminates the need 
for an additional surgical site.
40,41
 This reduces surgical time and minimizes 
postoperative pain.
34
 Like autografts, allografts provide good initial mechanical strength 
and promote cell proliferation and remodeling, with the added benefit of an unlimited 
graft supply.
19,39
 Nevertheless, there are still limitations to this therapy including disease 
transmission, bacterial infection, and unfavorable immunogenic responses.
18,42
 Although 
sterilization and preservation can minimize these risks, they also reduce the tensile 
properties of the graft, limiting its use for ACL reconstruction.
17,34,36,43,44
 
 
1.2.3 Synthetic Grafts 
Due to the limitations of biologic grafts, synthetic materials have been 
investigated for potential use in ACL reconstruction.
45,46
 These grafts do not require 
sacrifice of autogenous tissue and do not lose their strength due to tissue remodeling, 
which allows for much faster rehabilitation.
47
 Prostheses of homogenous, non-
degradable polymers evaluated for ACL repair include carbon fiber, the Gore-Tex 
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ligament (polytetrafluoroethylene), the Stryker-Dacron and Leeds-Keio ligaments 
(polyethylene terephthalate), and the Kennedy Ligament Augmentation Device 
(polypropylene).
5,9,18,33,46,48-50
 The Gore-Tex ligament is composed of a single, 
continuous fiber of expanded polytetrafluoroethylene (ePTFE) that is wound into 
multiple loops and joined together to form a braid.
51
 The Stryker-Dacron ligament 
consists of a core of four tightly woven Dacron tapes encased by a sleeve of loosely 
woven Dacron velour, and it was designed to promote tissue ingrowth.
41,52
 Similar to the 
Stryker-Dacron ligament, the Leeds-Keio ligament is composed of polyethylene 
terephthalate (PET) with an open-weave tube to promote ingrowth of fibrous tissue.
53,54
 
Finally, the Kennedy Ligament Augmentation Device (LAD) is a cylindrical prosthesis 
with a diamond-braided construction, and it was designed for simultaneous implantation 
with a biologic graft to augment the tissue and protect it during the early stages of 
healing.
55,56
 The Gore-Tex and Stryker-Dacron ligaments have each received general 
release from the Food and Drug Administration (FDA) as permanent ligament 
replacements, but only to salvage previously failed intra-articular reconstructions.
34,54
 
Although these devices typically provide immediate stabilization of the joint, 
they are unable to duplicate the mechanical behavior of the ACL and eventually fail due 
to material fatigue.
9,34
 Due to the high linear stiffness of synthetic implants, a majority of 
the physiological load is borne by the prosthesis, effectively stress shielding the 
surrounding tissue.
4,9,57,58
 Without proper mechanical cues to direct collagen alignment 
and tissue organization, the load-bearing capacity of the native tissue is reduced so that 
the synthetic graft is limited to its inherent fatigue properties. In addition to graft 
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rupture, repeated elongation of these devices can lead to permanent deformation at 
points of stress, which results in a loosening of the ligament and a loss of joint 
stabilization.
59,60
 Contact with sharp edges of the bone tunnels can also cause abrasions 
that weaken the implant and create debris, which can elicit an unfavorable foreign body 
response.
9,61
 Woven prostheses face additional challenges such as axial splitting, low 
extensibility, low tissue infiltration, and abrasive wear that can lead to synovitis in the 
joint.
4,5,9,57,58,62
 Long-term studies have also revealed a high incidence of osteoarthritis 
post implantation.
60,63
 Overall, the limitations of current ACL reconstruction strategies 
present a substantial margin for improvement in the escalating market for ACL repair. 
 
1.3  Anterior Cruciate Ligament Tissue Engineering 
 Musculoskeletal tissue engineering has received growing interest throughout 
orthopedic medicine as a promising alternative to biologic and synthetic grafts.
4,33,64,65
 
Tissue engineers attempt to harness the body’s natural ability to repair and regenerate 
damaged tissue through the application of biological, chemical, and engineering 
principles. This strategy can potentially improve upon current clinical options by 
providing appropriate biological and mechanical properties to regenerate damaged ACL 
tissue without the aforementioned limitations of other grafts.
4,5,9,66
 ACL reconstruction 
utilizing a tissue-engineered ligament would eliminate donor site pain and morbidity, 
improve and accelerate rehabilitation, provide a limitless supply of graft tissue, 
eliminate the risk of disease transmission or unfavorable immunogenic responses, and 
increase the fatigue life of the graft.
5,9
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 The traditional tissue engineering paradigm combines isolated cells and bioactive 
factors on a biodegradable scaffold that is able to sustain functionality during tissue 
regeneration. The scaffold serves as a structural template to enhance neotissue formation 
and structure, Figure 1.1.
5,9,66,67
 In ligament constructs, scaffolds are seeded with 
fibroblasts or mesenchymal stem cells that are then provided with the necessary 
mechanical and biochemical cues to initiate ligament regeneration. To facilitate this 
process, the biomaterial selected for these constructs must be biocompatible, 
biodegradable, and permit typical cell-material interactions necessary for cell 
proliferation, migration, and differentiation. The scaffold must also demonstrate 
interconnected porosity to enable nutrient transport, waste removal, and tissue 
infiltration. Finally, the tissue engineered construct must demonstrate appropriate 
mechanical behavior to maintain functionality throughout native tissue remodeling. The 
need to duplicate the complex function and unique mechanical properties of the ACL at 
all stages of remodeling is partly responsible for the difficulty encountered in developing 
a suitable surgical replacement. Therefore, advancement of ligament tissue engineering 
strategies is strongly dependent on the ability of tissue engineers to develop a 
biomaterial scaffold that reproduces both the mechanical and physiologic properties of 
native ACL tissue.  
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Figure 1.1. Tissue engineering paradigm.  
 
 
 
Knowledge of ligament structure and its components is extremely important in 
the development of a scaffold for ligament tissue engineering. Interactions among such 
components and their arrangement in the tissue give ligaments their unique mechanical 
properties.
4
 The ACL is predominantly composed of collagen, elastin, proteoglycans, 
glycoproteins, water, and fibroblasts.
4,68
 Fibroblasts not only synthesize fibrillar collagen 
but also enzymatically break down and remove old collagen as part of native tissue 
remodeling. Collagen account for almost 80% of all protein synthesis in the ACL. Type 
I and type III collagen comprise approximately 88% and 12%, respectively.
69,70
 Type I 
collagen forms tough, nonelastic cross-linked fibers that contribute to the tensile strength 
of ligaments and tendons.
68,70
 Type III collagen forms loosely organized, thin fibrils that 
 10 
 
  
provide elasticity.
68,70
 Type I collagen molecules form a hierarchical structure of dense, 
highly organized, cable-like tissue in which fiber bundles orient parallel to the 
longitudinal axis in a helical formation.
4,5,9,69,71
 Fibroblasts align between these collagen 
bundles and elongate in the direction of loading.
69
 Fiber bundles form a periodic crimp 
pattern that permits 7 to 16% creep before permanent deformation or ligament damage 
can occur. Overall, it is this complex, hierarchical structure that dictates the bulk tensile 
properties of the ACL. 
The mechanical and viscoelastic properties of the human ACL have been well-
documented. The human ACL is regularly exposed to cyclic loads as high as 630 N 
through all degrees of knee joint flexion/extension.
72
 Its ultimate tensile strength of was 
found to be 1730 N, with a linear stiffness of 182 N/mm and 12.8 N-m for energy 
absorbed at failure, although such properties have been found to increase during 
development and diminish with age.
73-75
 The maximum strain that a ligament can endure 
before failure is between 12 and 15%.
76
 When exposed to strain, the ACL demonstrates 
triphasic behavior, starting with a non-linear, toe region where the ligament exhibits low 
amount of stress per unit strain.
4
 This results from a lateral contraction of fibrils, the 
release of water, and straightening of the crimp pattern. Once the crimp pattern has fully 
straightened, force is directly applied to the collagen triple helix and interfibrillar 
slippage occurs between crosslinks, forming a linear region in which stress increases per 
unit strain.
77-79
 Eventually, collagen fibers begin to defibrillate, leading to a slight 
decrease in stress per unit strain and failure.
4,77,80
 A biomaterial scaffold that can 
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replicate this mechanical behavior and integrate with the native tissue is necessary for 
the development of a successful tissue engineered ligament, Figure 1.2. 
 
 
 
Figure 1.2.Stress-strain behavior of graft-tissue composite throughout the remodeling process. 
 
 
 
1.4  Current Biomaterial Scaffolds for Ligament Tissue Engineering 
1.4.1 Natural Polymer Grafts 
Biocompatible and degradable biomaterials that have been investigated for 
ligament tissue engineering include natural polymers, such as collagen and silk, and 
synthetic materials. Type I collagen was selected as a biomaterial scaffold due to its 
abundance in ligament tissue and its ability to support the growth of fibrous tissue. 
Examples of tissue-engineered approaches using collagen fibers are presented 
extensively throughout the literature.
81,82
 Dunn et al. constructed fibroblast-seeded 
scaffolds composed of type I collagen fibers and found that such devices remain viable 
after implantation, showing excellent biocompatibility, enhanced cell attachment, 
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proliferation, and extracellular matrix production.
82,83
 Nevertheless, these scaffolds are 
unable to maintain the mechanical integrity necessary to restore ligament function. 
Several strategies have been attempted to enhance the mechanical properties of collagen-
derived scaffolds, including cross-linking and copolymerization/blending with synthetic 
polymers.
9,34,84-90
. Despite these efforts, relatively quick in vivo degradation and the 
resulting loss of mechanical strength are still major concerns with using collagen fibers 
for ligament tissue engineering.
81,91
 High cost, variability, complex handling properties, 
and potential disease transmission further limit the use of collagen, prompting the search 
for an improved biomaterial.
34,92
 
 Due to its high tensile strength and linear stiffness, biocompatibility, and 
biodegradability, silk has received renewed interest as a potential biomaterial for tissue 
engineering.
93-97
 The excellent mechanical properties of silk result from the high 
homogeneity of its secondary structure (β-sheet), extensive hydrogen bonding, and 
crystallinity. Silk is composed of a fibroin core and a glue-like sericin cover, and 
although sericin in silk has been shown to cause adverse problems with 
biocompatibility, there are several methods to remove it before usage. As a result, 
scaffolds constructed of silk fibroin demonstrate good biocompatibility and have been 
shown to support cell adhesion.
98
 In addition, by coating the surface of these scaffolds 
with RGD sequences, increased cellular attachment, proliferation, and extracellular 
matrix production have been observed.
99
 When organized into an appropriate wire-rope 
geometry, silk fibroin exhibits mechanical properties similar to the native ACL.
98
 For 
example, Altman et al. constructed a tissue-engineered device consisting of a twisted 
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fibrous matrix composed of silk fibers arranged into a hierarchical structure similar to 
the native ACL. Through modification of scaffold architecture, the stiffness of the 
scaffold can also be decreased to prevent stress shielding while maintaining tensile 
strength. Silk undergoes proteolytic degradation at a rate that is dependent on its 
environment, but typically silk fibers lose their tensile strength within one year in vivo 
and degrade completely within two years. The slow rate of silk degradation allows for 
gradual load transfer from the polymer scaffold to newly formed tissue.
35
 Even though 
silk has demonstrated much promise for ligament tissue engineering, its dependence on 
scaffold architecture to achieve mechanical properties limits independent control of 
mechanical strength and degradation necessary to promote effective load transfer.  
Along with collagen and silk, other natural polymers have been investigated for 
potential use in ACL reconstructions. Funakoshi et al. constructed a tissue engineered 
scaffold from novel, chitosan-based hyaluronan hybrid polymer fibers, which were 
shown to exhibit enhanced mechanical properties and biological effects in vitro.
100
 
Majima et al. investigated the effect of alginate-based chitosan hybrid polymers on 
fibroblast adhesion, extracellular matrix synthesis, and mechanical properties.
100
 Finally, 
Messenger et al. investigated the ability of enamel matrix derivative to enhance tissue 
induction around scaffolds used in ACL reconstruction.
101
 These studies have 
considerable potential for ligament tissue engineering; however, they are still in 
preliminary stages of development and are far removed from clinical applications. 
Overall, despite the aforementioned advantages of natural polymers, major concerns 
stem from issues with mass production, variability, and the lack of independent control 
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of degradation rate and mechanical properties, which limits their usefulness for ACL 
repair. 
 
1.4.2  Synthetic Polymers Grafts 
In addition to natural polymers, biodegradable, synthetic polymers have been 
investigated for ACL repair, including poly (glycolic acid) (PGA), poly (L-lactic acid) 
(PLLA), poly (lactic-co-glycolic acid) (PLGA), polydioxanone (PDS), and poly 
(desamino-tyrosyl-tyrosine ethyl carbonate) (poly (DTE carbonate)).
4,66,102-108
 Similar to 
nondegradable synthetic polymers used to construct permanent prosthesis, there is no 
limit to graft supply and no risk of disease transmission. Unlike natural polymers, such 
as silk, which rely on modification of scaffold architecture to alter mechanical 
properties, the performance properties of synthetic polymers can also be controlled with 
polymer chemistry. For instance, the mechanical properties of a device may be 
controlled by altering the degree of polymer crystallinity or changing its molecular 
weight. 
 PGA and PLLA are excellent candidates for ligament tissue engineering because 
they are biocompatible, do not elicit unfavorable foreign body responses, and naturally 
degrade into non-toxic byproducts (glycolic acid, lactic acid). Additionally, because 
tissue engineered scaffolds are eventually replaced with neotissue, the fatigue properties 
of PGA and PLLA are not a concern. As a result, PGA, PLLA, and PLGA have been 
extensively studied for potential use in ACL reconstruction. 
4,66,104-108
 In particular, 
Laurencin et al. developed a series of cell-seeded, three-dimensional scaffolds from 
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PGA, PLLA, and PLGA using a novel braiding technique designed to enhance 
mechanical properties and promote tissue infiltration, with PLLA proving to be the best 
option for ACL repair.
37,109
 Similar to native ligament tissue, these braided scaffolds 
have a hierarchical structure composed of fibers arranged into bundles and wound 
throughout the thickness of the scaffold. This braiding technique was developed to 
create scaffolds with controlled pore size, integrated pores, resistance to wear and 
rupture, and mechanical properties comparable to the ACL. In in vitro studies, ACL 
fibroblasts were found to conform to the geometry of the scaffolds, exhibit spindle-like 
morphologies, and demonstrate extracellular matrix production. Additionally, cellular 
proliferation, tissue growth, and long-term extracellular matrix production were 
enhanced in the presence of fibronectin, an adhesion protein found in the extracellular 
matrix of native ligament tissue. These results suggest that braided scaffolds constructed 
of PLLA may become a viable option for ACL repair.
37,109,110
  
Other synthetic polymers explored for potential use in ligament tissue 
engineering include PDS and poly (DTE carbonate). Buma et al. studied autogenous 
reconstruction of the ACL in goats in the presence of a degradable augmentation device 
composed of PDS and found that, after 6 weeks, a rapid decrease in strength was 
observed for augmented transplants.
103
 In contrast, non-augmented transplants 
demonstrated a gradual increase in strength. These results suggest that PDS is a poor 
choice for ligament tissue engineering due to its rapid degradation. Bourke et al. 
fabricated ACL scaffolds from poly (DTE carbonate) fibers and found that these 
scaffolds have mechanical properties similar to the native ACL, and that they keep a 
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much higher ultimate tensile strength (87% of original) after 30 weeks of degradation 
than PLLA (7% of original).
102
 Despite these advantages, the parallel arrangement of 
poly (DTE carbonate) fibers in these scaffolds leaves them susceptible to long-term 
failure due to fatigue and creep. 
Overall, current research has shown that synthetic, biodegradable polymers can 
be viable options for ACL reconstruction; however, these materials are still limited in 
their ability to serve as ligament replacements. This is because the majority of these 
polymers lack the inherent material properties necessary to restore the mechanical 
strength and elasticity of the ACL. To overcome these mechanical limitations, a number 
of scaffolds derive their properties from their geometry and method of fabrication; 
however, this requires an understanding of how each structure behaves mechanically 
relative to one another. Changes in the mechanics of scaffold architecture due to 
degradation or repeated loading then increase the complexity of the graft, making it 
difficult to optimize scaffold design to promote effective load transfer. In addition to 
scaffold fabrication, polymer chemistry can be tailored to modulate these performance 
properties; however, a number of these structure-property relationships have overlapping 
components that complicate material design. For example, it is widely accepted that 
polymer crystallinity can be used to predict polymer modulus, yet highly crystalline 
polymers have also been shown to demonstrate slower hydrolytic degradation than 
amorphous polymers.
111
 Without mechanisms to isolate specific structure-property 
relationships, these polymers are unable to balance the dual impact of tensile properties 
and the rate of degradation on the regeneration of ligament tissue. Additionally, the 
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degradation mechanism for the majority of these polymers is non-specific hydrolysis, 
which makes it difficult to tailor scaffold degradation to complement neotissue 
formation. An improved material is needed to develop a successful tissue engineered 
ligament, because synthetic polymers are typically unable to either match the 
mechanical behavior of the ACL or integrate with native tissue remodeling. 
 
1.5  Segmented Polyurethane Elastomers 
 Due to the aforementioned limitations of current synthetic polymers, 
polyurethane elastomers have received growing interest for ligament tissue 
engineering.
112-115
 Polyurethanes were first developed by Otto Bayer of I. G. 
Farbenindustrie, Leverkusen, Germany, in 1937.
112
 Since then, polyurethanes have been 
used in a wide range of industrial applications, including machinery, textiles, packaging, 
adhesives, and sealants.
116,117
 Because of their outstanding mechanical properties and 
established biocompatibility, polyurethanes have also been used in a variety of 
biomedical applications over the past 40 years.
112,118-120
 Polyurethane chemistry dictates 
the physical, biological, and mechanical properties of these polymers and can be tailored 
to provide a variety of materials, such as soft elastomers, rigid thermosets, and 
foams.
112,116,117,121
 Therefore, understanding the hierarchical structure of polyurethanes 
and related materials, along with relevant structure-property relationships, is essential 
for effective biomaterial design. 
 Polyurethanes are a class of polymers that consist of urethane (-NH-CO-O-) 
linkages, typically generated by the reaction of isocyanates with hydroxyl-functional 
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molecules by addition to the carbon-nitrogen bond.
121-123
 Similarly, polyureas contain 
urea linkages (-NH-CO-NH-) and are generated by the addition of isocyanates and  
primary amine groups. Polyurethane and polyurea elastomers used for biomedical 
applications are typically linear, alternating block copolymers that consist of 
comparatively high molecular weight soft segments linked with urethane/urea 
containing hard segments.
112-114
 Common soft segments include hydroxyl-terminated 
polyethers, polyesters, and polycarbonates, all of which have relatively low glass 
transition temperatures. In contrast, hard segments usually have high glass transition 
temperatures and are characterized by semicrystalline, aromatic or aliphatic 
diisocyanates linked with a low molecular weight chain extender.
112
 Thermodynamic 
incompatibility between these segments drives microphase separation in which hard 
segments form glassy, semicrystalline domains that, in polymers of lower hard segment 
content, are dispersed within an amorphous, rubbery matrix.
112-114,124,125
 These hard 
domains are stabilized by hydrogen bonds formed between urea and urethane linkages 
which then serve as physical crosslinks and retain and reinforce the soft segment 
matrix.
112,124,125
 It is this microphase-separated morphology that dictates the ease of 
processing of polyurethane elastomers. This is because, unlike traditional elastomers 
which derive their elasticity from an amorphous network interconnected with chemical 
crosslinks, the physical crosslinks of polyurethane elastomers are thermo-reversible and 
so breakup upon heating or dissolution. 
Along with this ease of processing, the mechanical properties of segmented 
block copolymers are strongly dependent on this microphase-separated morphology. 
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Deformation of segmented block copolymers begins with elastomeric stretching of the 
soft segment matrix, as indicated by a low initial modulus in the stress-strain curve, 
Figure 1.3.
126
 Hard domains then breakup at flaws and begin to rotate into the strain 
direction, causing a plateau of almost constant stress. This eventually results in the 
formation of microfibrils consisting of small, semi-crystalline hard domains separated 
by strain-crystallized soft segment chains that undergo strain hardening at higher 
strains.
126
 Ultimately, these hard domains shear yield at a critical strain and the material 
fails.
126
. Because of this deformation profile, polyurethanes and polyureas have excellent 
mechanical properties, including high tensile strength, elongation to failure, fatigue life, 
and wear resistance, without additional processing. In addition to mechanical behavior, 
microphase separation has also been shown to directly influence the rate and extent of 
biodegradation.
127,128
 Factors that influence the degree of phase separation include soft 
segment molecular weight, hard and soft segment chemistries, and the hard to soft 
segment ratio.
129-133
 Therefore, these variables can be adjusted to modulate the 
performance properties of polyurethanes and polyureas. For example, increased hard 
segment content puts greater constraint on the soft segment matrix, which leads to a 
higher initial modulus and strain hardening at a lower strain.
126,134
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Figure 1.3. Effect of mechanical stretch on polyurethane deformation. Reprinted with 
permission from “Relationship between nanoscale deformation processes and elastic 
behavior of polyurethane elastomers”, by Christenson, EM, Anderson, JM, Hiltner, A, 
Baer, E, Polymer, 46(25):11744-11754, Copyright 2005 by Elsevier.
126
 
 
 
Overall, the correlation between polyurethane chemistry and microphase 
separation, and thus performance properties, provides a means to elucidate key 
structure-property relationships. As with homogenous, biodegradable polymers, a 
number of these relationships have overlapping components that complicate material 
design for tissue engineering applications. A key challenge then is to isolate structure-
property relationships that are essential to the development of engineered tissue. A 
polymer system with several mechanisms to modulate physical properties would provide 
the tools necessary to observe such phenomena. Due to the exceptional tunability of 
polyurethanes and polyureas, segmental modification of these polymers can be used to 
generate a library of polymers with broad structural diversity and a myriad of 
performance properties to better probe specific tissue-biomaterial interactions. Greater 
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understanding of such structure-property relationships would then allow for rational 
design of a tissue engineered scaffold that promotes effective load transfer. 
 
1.6  Biodegradable Polyurethane Scaffolds 
As stated previously, in addition to the aforementioned mechanical requirements, 
tissue engineered scaffolds must be biocompatible and biodegradable. Polyurethanes 
used for biomedical applications have traditionally been intended for biostable, long-
term use, such as cardiovascular applications and artificial organs.
112,120
 Aromatic 
diisocyanates were often chosen for these materials due to their enhanced mechanical 
properties; however, concerns that the degradation of these diisocyanates (i.e., 4,4’-
methylenediphenyl diisocyanate (MDI), 2,4-toluene diisocyanate (TDI)) can generate 
potentially carcinogenic byproducts (i.e., 4,4’-methylenedianiline (MDA), 2,4-toluene 
diamine (TDA)) have limited their transition to biodegradable polymers.
115,135-137
 As a 
result, aliphatic diisocyanates, such as hexamethylene diisocyanate (HDI) and L-lysine 
diisocyanate (LDI), have received interest for tissue engineering.
132,138-149
 Unlike 
aromatic diisocyanates, polyurethanes prepared from aliphatic diisocyanates have been 
reported to degrade to non-cytotoxic compounds in vitro and in vivo.
150,151
 LDI and 
HDI-based biodegradable polyurethanes have also demonstrated excellent mechanical 
properties and good biocompatibility, as well as promoted cell-material interactions 
necessary for tissue formation.
152-154
 In addition to biocompatible diisocyanates, 
biodegradable hard segments composed of enzyme-labile chain extenders have been 
used to synthesize polyurethanes for tissue engineering.
142,151,155
 Degradation of these 
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linkages is dependent on hard segment crystallinity; however, crystallinity is a well-
established barrier to degradation. Additionally, enhanced hard segment crystallinity 
leads to an increase in supramolecular interactions (i.e., hydrogen bonding) that dictate 
the mechanical properties of polyurethane elastomers. Due to the interactions among 
crystallinity, degradation rate, and mechanical strength, biodegradable hard segments 
limit the inherent tunability of polyurethane elastomers by inhibiting independent 
control of these structure-property relationships.  
In contrast, the use of biodegradable soft segments can potentially decouple the 
effects on polyurethane structure on degradation rate and mechanical properties. 
Polyurethanes have been synthesized from a number of biodegradable soft segments, 
including poly (lactic acid), poly (glycolic acid), and poly (ε-caprolactone) (PCL).139-
143,149,156-162
 These polyols were selected based on their established hydrolytic 
degradation in vitro and in vivo. As a result, polyurethane degradation is dependent on 
soft segment content, chemistry, and molecular weight. Several polyurethanes composed 
of these polyols have demonstrated biocompatibility and excellent mechanical 
properties, as well as promoted tissue remodeling.
151,159
 Indeed, Gisselfalt et al. 
developed a series of PCL-based poly(urethane urea) fibers for ligament tissue 
engineering that displayed high tensile strength, modulus, and fatigue resistance, as well 
as supported ingrowth of connective tissue.
134,163
 Nonetheless, as with biodegradable 
polyesters previously used for ligament tissue engineering, degradation of these soft 
segments is dictated by non-specific hydrolysis, which makes it difficult to tailor 
polyurethane degradation to complement tissue regeneration.  
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However, the semi-crystalline nature of some of these soft segments can impact 
the performance properties of these materials. For example, PCL of higher molecular 
weight can lead to increased crystallinity of the soft segment, and thus a corollary 
increase in the modulus and tensile strength, along with a decreased rate of 
degradation.
132,142
 Therefore, soft segment crystallinity further compounds the 
complexity of polyurethane morphology and derived properties, which makes 
independent control of polyurethane structure-property relationships through segmental 
modifications difficult. In order to disrupt the crystallinity of PCL and increase the range 
of degradation rates, PCL and poly (ethylene glycol) (PEG) copolymers have been 
investigated; however, the hydrophilicity of PEG increases water uptake, which 
increases the rate of degradation.
150,156,159,164-166
 Overall, although segmented block 
copolymers possess the tools necessary to tailor biomaterial chemistry and thus provide 
independent control of degradation and mechanical properties, non-specific degradation 
of current polyurethane elastomers makes it difficult to complement scaffold 
degradation with ligament regeneration. 
 
1.7  System-Responsive Degradation 
In general, the design of biomaterial scaffolds for tissue engineering is currently 
limited by the ability of the scaffold to restore function throughout the life of the 
implant. The scaffold must provide initial mechanical stability and function, but must 
retain adequate strength and function while the scaffold degrades and neotissue is 
formed. The rate of degradation in polymers such as polyesters (which undergo non-
specific degradation via hydrolysis) is dependent on the environment, which is heavily 
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dependent on the individual. Temperature, pH, and mechanical stresses can cause 
degradation to vary significantly, complicating design of a scaffold to fit a certain 
degradation profile. Due to this dependency on mechanical loading, a major challenge in 
the design of a successful tissue engineered ligament is to facilitate load transfer from 
the biodegradable scaffold to newly formed tissue. Initially, the biodegradable scaffold 
should exhibit sufficient mechanical properties to provide immediate mechanical 
stability and restoration of ligament function. Isolated cells should then generate 
neotissue at a rate complementary to scaffold degradation so that the mechanical 
integrity of the ligament is sustained throughout the remodeling process up until the 
injured tissue is completely replaced.
4,9,167
 Because the level of load borne unto de novo 
tissue dictates remodeling and thus, collagen alignment, a degradation rate that does not 
match new tissue formation can lead to either graft rupture (too fast) or stress shielding 
(too slow).
4,66,98
 With stress shielding, the lack of collagen alignment can shift the 
dynamics of ligament remodeling toward degradation, which reduces the load-bearing 
capacity of the newly formed tissue. In order to integrate with native ligament 
remodeling and maintain mechanical functionality, new structure-property models are 
needed to elucidate the mechanisms of load transfer. A polymeric system with control 
over degradation rate and mechanical properties would provide insight into these 
mechanisms and allow for rational design of tissue engineered constructs. Biodegradable 
polyurethanes can be tailored to isolate the effects of polymer structure on specific 
performance properties; however, utilizing non-specific degradation remains 
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problematic, given that these rates can vary based on the individual, environment, and 
circumstances. 
Appropriate mechanical cues are required for neotissue to successfully form the 
hierarchical structure of ACL tissue. Independent control over mechanical properties and 
degradation would allow for tailoring of degradation to compliment neotissue formation, 
and prevent premature graft rupture. Current research has established that mechanical 
stimulation increases fibroblast proliferation. It has been shown that the extent of this 
effect is dependent on the type and magnitude of this loading, as well as the 
duration.
66,168-171
 In addition, cyclic stretch has been shown to cause cells to adopt an 
elongated morphology consistent with the ligament phenotype.
168,172-175
 Mechanical 
loading is also needed to induce cellular alignment via restructuring of the actin 
cytoskeleton.
172,176,177
 The orientation of fibroblasts with respect to mechanical loading 
is of particular winterest because of its influence on de novo tissue formation.
173,178-181
 
Fibroblasts oriented parallel to the direction of stretch demonstrate greater protein 
synthesis than cells aligned perpendicular to the direction of stretch, as well as generate 
an oriented collagen matrix.
173,178
 These effects have clear relevance to the mechanical 
properties of the resulting tissue. Finally, physical loading has been shown to increase 
protein synthesis, specifically type I collagen, which is of particular importance in the 
ACL due its role in establishing tensile properties.
168,172-174,177,182-184
 Overall, these 
studies establish the need for mechanical stimulation to develop highly organized, cable-
like tissue, indicative of the native ACL. 
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System-responsive degradation would circumvent this limitation by integrating 
polyurethane biodegradation with native ligament remodeling. As stated previously, 
during tissue regeneration, fibroblasts produce enzymes that systematically break down 
and remove the existing extra cellular matrix.
185
 Specifically, matrix metalloproteinase 
(MMP) production, including MMP-1 and MMP-2, is upregulated due to a ligamnent 
injury such as a rupture and mechanical stimulation. Additionally, it has been 
demonstrated that MMP-2 is the most efficient enzyme associated with type I collagen 
degradation.
186-188
 The specificity of these enzymes has been extensively investigated 
with cleavage localized to the (Gly775-Ile776) site of the triple-helical collagen.
189-191
 By 
incorporating this collagen oligopeptide sequence into the design of a novel biomaterial, 
guided scaffold degradation can be achieved. Moreover, integration of this enzyme-
labile peptide sequence into the soft segment of a polyurethane elastomer would provide 
a means to decouple degradation rate from other performance properties.  
For this study, an enzyme-labile peptide sequence with established specificity to 
MMP-2 was conjugated to ether-based polyols to form collagen-mimetic soft segments, 
Figure 1.4. Synthetic routes were first developed that would allow for the chemical 
incorporation of a diamine functional peptide into a polymer backbone. Upon successful 
conjugation, biodegradable soft segments were used in the synthesis of linear polyurea 
elastomers. By varying soft segment chemistry, soft segment molecular weight, and the 
hard to soft segment ratio, a series of cell-responsive, biodegradable polyureas was 
developed to elucidate key structure-property relationships necessary to complement 
neotissue formation. Overall, a novel biomaterial that combines the strength and 
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tunability of synthetic elastomers with cell-responsive degradation will assist in the 
development of an improved tissue engineered graft for ACL reconstruction. 
 
Figure 1.4. Synthetic design of cell-responsive, biodegradable polyureas. 
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CHAPTER II 
MODEL BIOSTABLE POLYUREAS 
2.1 Introduction 
Polyureas are a class of segmented block copolymers that are similar to 
polyurethanes in many aspects. Urea linkages are formed by the reaction of isocyanates 
with amines, rather than hydroxyl groups. This reaction is much more energetically 
favorable, allowing for reaction at room temperature without catalyst
192,193
. 
Thermoplastic polyurea may be described as linear, alternating block copolymers 
consisting of comparatively high molecular weight soft segments linked with urea 
containing hard segments (HS).
112-114,194
 Polyurea HS consist of diisocyanate molecules 
linked with short diamine chain extenders.
112
 Changes in soft segment chemistry, soft 
segment molecular weight, HS chemistry, and HS content, among other factors, have 
been shown to affect the degree of phase separation and resulting mechanical 
properties.
129-133,195-199
 This tunable segmental chemistry provides multiple avenues to 
modulate mechanical properties to meet specific design targets.  
In addition to requirements of elasticity and fatigue resistance, review of the 
properties of the ACL and loading can be used to identify requisite strength of polyurea 
ligament grafts. The size and strength of the human ACL ranges widely depending on 
the individual’s age and gender, and varies significant within these groups as well. One 
study reported an average cross sectional area of the middle portion of the ACL to be 
60.1 mm ± 16.9 mm
2
.
200
 Another study found a peak walking load of 303 N.
201
 This 
would then produce a tensile stress of 5.04 MPa. Criteria for a potential tissue 
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engineered ligament graft were established as an ultimate tensile strength of 10 MPa, 
approximately two times the average load while walking. 
Hard segment content is one of the strongest predictors of strength in segmented 
polyureas with higher HS content yielding greater strength.
199
 However, higher HS 
content is also associated with gelation during synthesis which can prevent high 
molecular weight formation and difficulty in processing. Gelation is a much more 
significant issue in polyureas due to the formation of “bidentate” hydrogen bonds in 
which both hydrogens within the urea linkage hydrogen bond with the two free electron 
pairs of an oxygen atom in a nearby carbonyl, Figure 2.1. These bidentate hydrogen 
bonds can become so strong that reaction solutions gel and become unprocessable even 
upon dilution, significant heat, and the addition of hydrogen bond disruptors. Alteration 
in chain extender chemistry including changes in HS registry, symmetry, and sterically-
hindering groups have been used to prevent gelation and improve processability by 
limiting hydrogen bonding.
202,203
 
 
 
Figure 2.1. Comparison of hydrogen bonding in polyureas and polyurethanes. 
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In this study, segmental modification of polyurea chemistry was used to identify 
compositions that maintained target mechanical properties without gelation. Given the 
expense of peptides and the potentially confounding impact on phase morphology and 
mechanical properties, model polyurea compounds without peptide were investigated to 
elucidate key structure-property relationships prior to synthesis of peptide-based 
polyureas. The effect of increasing hard segment content on tensile strength was 
investigated in conjunction with the effect of chain extender chemistry on hydrogen 
bonding and gelation. Candidate hard segment content and chemistry selected from 
these studies was then used in a subsequent study focused on determining the effect of 
soft segment chemistry on polyurea morphology and mechanical properties. Overall, the 
methodology developed in these studies was used to identify candidate compositions 
with suitable mechanical properties for subsequent biodegradable formulation testing. 
 
 2.2 Materials 
Polyether diamines (Mn=1700-2000 Da) were acquired from Huntsman 
Corporation®, Figure 2.4. Poly(ethylene glycol) (PEG) based polyether diamine, (trade 
name ED-2003, Mn=2000 Da), poly(propylene glycol) (PPG) polyether diamine, (trade 
name D-2000, Mn=2000 Da), poly(tetramethylene glycol) (PTMG) polyether diamine, 
(trade name XTJ-548, Mn=1700 Da) were used. Polymers were azeotropically dried by 
dissolving in toluene at a concentration of 100 mg/mL and then removed by rotary 
evaporation at 100 ºC. Note that ED-2003 is predominantly comprised of PEG (n≈39), 
but is capped with ~3 repeat units of PPG adjacent to each amine end group. The XTJ-
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548 also has a slightly lower Mn and contains a fraction of secondary amines according 
to the manufacturer. Hexane diisocyanate HDI, ethylene diamine (EDA), 1,2-
diaminopropane (2DAP), 1,3-diaminopropane (3DAP), and lithium bromide (LiBr) were 
obtained from Sigma Aldrich and used as received. Anhydrous dimethylformamide 
(DMF) was obtained from Sigma Aldrich and stored over molecular sieves.  
 
 
  
Figure 2.2. Candidate polymers used as the polyurea soft segment. 
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2.3 Methods 
Polyureas were created in a one-pot synthesis with serial addition of reagents. 
Reactions were performed in a reaction vessel under a dry blanket of nitrogen gas with 
vigorous stirring. Polyether diamines were dissolved in DMF at a concentration of 25 
mg/mL. The polymer solution was then added to a 50 mg/mL solution of HDI in DMF, 
forming the diisocyanate-functionalized prepolymer. A 10 mg/mL solution of the chain 
extender in DMF was then added drop-wise to build molecular weight, Figure 2.3. 
 
Figure 2.3. Synthesis of model biostable polyureas. 
 
Fourier transform infrared (FTIR) spectroscopic analysis was performed on a 
Bruker TENSOR 27 spectrometer to confirm reaction completion and extent of 
hydrogen bonding. Polymer solutions were cast onto glass petri dishes at 50°C under a 
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nitrogen blanket and dried under vacuum starting at -200 mbar relative to atmosphere 
and then decreasing 200 mbar every 6 hours followed by full vacuum at 0 mbar for 24 
hours. Resulting films were approximately 0.2 mm in thickness. Molecular weight was 
determined by gel permeation chromatography using a Viscotek GPCMax using 
Phenomenex columns with 10
3 
Å, 10
4 
Å, and 10
5 
Å pores, with a mobile phase of DMF 
with 0.05 M LiBr. GPC samples were acquired by diluting 100 µL samples of the 
reaction solution in 900 µL of DMF with 0.1 M LiBr at 80ºC for 1 hour. Not all polymer 
solutions were sufficiently dissolved to perform GPC analysis. Dynamic mechanical 
analysis (DMA) was performed on film strips of approximately 5 mm × 22 mm × 0.2 
mm in size using a TA Instruments RSA3 instrument. Temperature sweep tests were 
performed from -90ºC to 150ºC with a heating rate of 5ºC/min with a 200 g load cell. 
Finally, dogbone specimens were cut from films for tensile testing with an Instron 3345 
Single Column Universal Testing System equipped with a 1 kN load cell and 250 N 
pneumatic grips, tested at 100% strain/minute. Percent recovery was measured after 
specimens were strained to failure. 
 
2.4 Results and Discussion 
2.4.1 Effect of Increased Hard Segment Content on Mechanical Properties 
Due to the high degree of hydrogen bonding found in polyureas, compositions 
approaching 15% HS content would commonly gel and become unprocessable and 
unusable. Therefore, HS content was first modulated from 10 to 14 wt% to determine 
the resulting effect on polyurea mechanical properties. A table of reagents is provided, 
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Table 2.1. Syntheses of polyureas with altered HS content were performed as previously 
described using PEG based soft segments due to their established use in tissue 
engineering constructs. Polyurea solutions varied in viscosity from a liquid to semi-
solid. FTIR spectroscopy was used to confirm reaction completion and degree of 
hydrogen bonding, Figure 2.4. Spectra were baseline corrected and normalized to the 
ether backbone (1080 cm
-1
) as an internal reference for hard segment content. Spectral 
analysis indicated full reaction completion as evidenced by loss of the isocyanate peak          
(2260 cm
-1
). Significant urea formation was observed (1650 cm
-1
), as well as hydrogen-
bonded urea (1617 cm
-1
), both intensify with increasing HS content. In samples with 
higher HS content, hydrogen bonded N-H groups were also observed (3500 cm
-1
). 
 
 Table 2.1. Reactants in PEG based polyureas with 10%, 12%, and 14% HS content.  
PU-10HS 
Molecular Weight 
(kDa) 
Grams mL 
molar 
ratio 
mmols 
PEG Diamine 2000 1.650 1.650 1.00 0.825 
HDI (total) 168.2 0.172 0.164 1.24 1.023 
EDA 60.1 0.012 0.013 0.24 0.198 
      
PU-12HS 
Molecular Weight 
(kDa) 
Grams mL 
molar 
ratio 
mmols 
PEG Diamine 2000 1.650 1.650 1.00 0.825 
HDI (total) 168.2 0.203 0.194 1.46 1.2045 
EDA 60.1 0.023 0.026 0.46 0.3795 
      
PU-14HS 
Molecular Weight 
(kDa) 
Grams mL 
molar 
ratio 
mmols 
PEG Diamine 2000 1.650 1.650 1.00 0.825 
HDI (total) 168.2 0.235 0.224 1.69 1.3943 
EDA 60.1 0.034 0.039 0.69 0.5693 
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 Figure 2.4. FTIR spectra of PEG polyureas containing 10%, 12%, and 14% HS content. 
 
The stress–strain behavior of polyureas with increased HS content is similar to a 
semi-crystalline polymer above its Tg.
204
 Polyureas displayed a yield point followed by 
drawing similar to semi-crystalline PEG polyurethanes reported in the literature.
132,205-207
  
Polyureas with 10% HS were characterized by a 2% secant modulus of 30.1 MPa ± 6.7 
MPa, an ultimate elongation before failure of 1150% ± 10%, and an ultimate tensile 
strength of 10.6 MPa ± 1.5 MPa. Polyureas with 12% HS were characterized by a 2% 
secant modulus of 43.8 MPa ± 6.6 MPa, an ultimate elongation before failure of 1150% 
± 60%, and an ultimate tensile strength of 13.8 MPa ± 0.6 MPa. Polyureas with 14% HS 
were characterized by a 2% secant modulus of 49.2 MPa ± 4.1 MPa, an ultimate 
elongation before failure of 1230% ± 10%, and an ultimate tensile strength of 24.2 MPa 
± 0.5 MPa, Figure 2.5, Table 2.2. The increase in modulus and tensile strength was 
attributed to the increase in HS content. Previous literature has shown that increased HS 
8001100140017002000230026002900320035003800
Wavenumber (cm-1) 
PU-14HS
PU-12HS
PU-10HS
(N-H) 3500 cm-1 
H-Bonded 3300cm-1 
Methyl Backbone (C-C)  
Urea (C=O) 1650 cm-1 
H-Bonded 1617 cm-1 
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content puts greater constraint on the soft segment matrix, leading to a higher initial 
modulus.
126,134
 Several studies have attributed enhanced tensile properties to both 
increased phase separation and soft segment crystallinity.
207,208
 All polyureas were 
observed to have a significant permanent set with percent recovery calculated to be 
298% ± 28% for polyureas with 10% HS, 352% ± 23% for polyureas with 12% HS, and 
398% ± 36% for polyureas with 14% HS. Given the relative high recovery of other 
polyether-based polyurethanes, the permanent set was attributed to the deformation of 
soft segment crystalline domains.  
 
Figure 2.5. Stress-strain response of PEG polyureas with 10%, 12%, and 14% HS 
content. 
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Table 2.2. Tensile properties of polyureas with 10%, 12%, and 14% HS content. 
Polyurea 
Modulus 
(MPa) 
Elongation 
(%) 
Strength 
(MPa) 
Permanent 
Set (%) 
PU-10HS 30.1 ± 6.7 1150 ± 10 10.6 ± 1.5 298 ± 28 
PU-12HS 43.8 ± 6.6 1150 ± 60 13.8 ± 0.6 352 ± 23 
PU-14HS 49.2 ± 4.1 1230 ± 10 24.2 ± 0.5 398 ± 36 
 
 
2.4.2 Effect of Registry on Hydrogen Bonding and Gelation 
Preliminary studies indicated that HS content of 15% was the threshold for 
gelation in PEG based polyureas. PPG based polyureas were even more difficult to 
synthesize and were unable to reach 10% HS content without gelation. Given that 
improved tensile properties were observed at higher hard segment contents, additional 
studies were conducted in an effort to prevent gelation at higher hard segment contents 
and extend pot life. To this end, PEG based polyurea compositions were formulated to 
explore the effect of HS registry on hydrogen bonding and the corollary effects on 
gelation. Based on preliminary studies, 15% HS content was selected for these studies. 
Chain extender composition was modulated to investigate the effect of HS registry with 
mixed symmetry (A), mixed length (B), and/or sterically-hindered diamines (C), Figure 
2.6. 
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Figure 2.6. HS registry resulting from altered chain extender chemistry using: mixed 
symmetry (A), mixed length (B), and/or sterically-hindered diamines (C). 
Syntheses of polyureas were performed as previously described using PEG based 
soft segments with altered HS chemistry. Resulting polyurea solutions varied in 
viscosity from a viscous liquid to a semi-solid. Polyureas were formulated to test mixed 
length (EDA and BDA), mixed symmetry (EDA and 3DAP), and a combination of 
mixed length, symmetry, and sterically-hindering groups (2DAP and 3DAP) compared 
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to polyureas utilizing EDA alone. A table of reagents is provided, Table 2.3. All 
polyureas with the exception of those made with a combination of 2DAP and 3DAP 
increased in viscosity (gelled) such that cast films resulted in cracked, unusable films. 
FTIR spectral analysis was performed as described previously to determine the effect of 
chain extender chemistry on the degree of hydrogen bonding. All spectra displayed 
significant hydrogen bonding of the urea hard segment (1617 cm
-1
), Figure 2.7. It was 
found that polyureas chain extended entirely with EDA had the highest viscosity and 
almost all urea displayed hydrogen bonding (1617 cm
-1
). Polyureas created with a 1:1 
mixture of the even-length diamines EDA and BDA had the next highest viscosity as 
well as a shoulder at 1617 cm
-1
, indicating a measure of hydrogen bonding. Polyureas 
created with a 1:1 mixture of EDA and 3DAP, varying length and symmetry, showed 
similar viscosity to the EDA-BDA mixture and a small increase in hydrogen bonding. 
Polyureas synthesized using a 1:1 mixture of 2DAP and 3DAP had the lowest viscosity 
and minimal evidence of hydrogen bonding. Polyureas using this mixture of 2DAP and 
3DAP were the only solutions found to make cohesive films via film casting. It was 
hypothesized that this mixture of diamines with different length, symmetry, and 
sterically-hindering groups had an additive effect, reducing hydrogen bonding better 
than the other formulations alone. This formulation was able to prevent gelation and 
improve processability. 
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Table 2.3. Reactants in PEG based polyureas containing chain extender mixtures of 
EDA, BDA, 2DAP, and 3DAP. 
PU-EDA 
Molecular 
Weight (kDa) 
Grams mL molar ratio mmols 
PEG Diamine 2000 3.305 3.305 1.0000 1.6523 
HDI (total) 168.2 0.549 0.525 1.6800 3.2656 
EDA 60.1 0.040 0.045 0.3400 0.6609 
      
PU-EDA-BDA 
Molecular 
Weight (kDa) 
Grams mL molar ratio mmols 
PPG Diamine 2000 3.305 3.305 1.0000 1.6523 
HDI (total) 168.2 0.507 0.484 1.5500 3.0129 
EDA 60.1 0.032 0.036 0.2750 0.5346 
BDA 88.15 0.047 0.054 0.2750 0.5346 
      
PU-EDA-3DAP 
 
Molecular 
Weight (kDa) 
Grams mL molar ratio mmols 
PTMG Diamine 1700 3.305 3.305 1.0000 1.9438 
HDI (total) 168.2 0.513 0.490 1.5700 3.0518 
3DAP 74.12 0.041 0.046 0.2850 0.554 
EDA 60.1 0.033 0.038 0.2850 0.554 
      
PU-2DAP-3DAP   
Molecular 
Weight (kDa) 
Grams mL molar ratio mmols 
PTMG Diamine 1700 3.305 3.305 1.0000 1.9438 
HDI (total) 168.2 0.507 0.484 1.5500 3.0129 
3DAP 74.12 0.040 0.045 0.2750 0.5346 
2DAP 74.13 0.040 0.046 0.2750 0.5346 
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Figure 2.7. FTIR spectra of PEG based polyureas containing chain extender mixtures of 
EDA, BDA, 2DAP, and 3DAP 
 
2.4.3 Effect of Soft Segment Chemistry on Morphology and Mechanical Properties 
The mixture of 2DAP and 3DAP at 15% HS content was selected for subsequent 
testing of the effect of soft segment chemistry due to its ability to reduce hydrogen 
bonding and prevent gelation. Polyureas with alternate soft segment chemistries were 
synthesized as described previously using PEG, PPG, and PTMG diamine based soft 
segments to investigate the effect on polyurea structure on morphology and mechanical 
properties. A Table of reagents is provided, Table 2.4. There was no evident difference 
in polyurea solution viscosity. FTIR spectral analysis was used as described above to 
assess hydrogen bonding, Figure 2.8. PEG polyureas were found have the least 
hydrogen bonding, followed by PPG, and PTMG. In addition to hydrogen bonding of 
the urea carbonyl, hydrogen bonding of N-H groups was observed (3500 cm
-1
) and more 
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pronounced in PPG and most in PTMG based polyureas. The presence of hydrogen 
bonded N-H stretching with decreased hydrogen bonded urea indicates that a portion of 
the hydrogen bonding can be attributed to interactions between the hard segment and 
soft segment.
209,210
 The reduced number of ether linkages in PTMG relative to PEG and 
PPG is thought to reduce the number of hydrogen bond acceptors and therefore reduce 
the propensity for hard segments to hydrogen bond with soft segments. FTIR indicates 
PPG has slightly higher HB urea, which is attributed its hydrophobicity, which has been 
shown to increase phase separation HB urea.
210
 
  
Table 2.4. Reactants in PEG, PPG, and PTMG polyureas containing 15% HS content. 
PU-PEG 
Molecular 
Weight (kDa) 
Grams mL molar ratio mmols 
PEG Diamine 2000 3.305 3.305 1.0000 1.6523 
HDI (total) 168.2 0.579 0.553 1.7700 3.4406 
3DAP 74.12 0.055 0.062 0.3850 0.7484 
2DAP 74.13 0.055 0.064 0.3850 0.7484 
      
PU-PPG 
Molecular 
Weight (kDa) 
Grams mL molar ratio mmols 
PPG Diamine 2000 3.305 3.305 1.0000 1.6523 
HDI (total) 168.2 0.579 0.553 1.7700 3.4406 
3DAP 74.12 0.055 0.062 0.3850 0.7484 
2DAP 74.13 0.055 0.064 0.3850 0.7484 
      
PU-PTMG 
Molecular 
Weight (kDa) 
Grams mL molar ratio mmols 
PTMG Diamine 1700 3.305 3.305 1.0000 1.9438 
HDI (total) 168.2 0.507 0.484 1.5500 3.0129 
3DAP 74.12 0.040 0.045 0.2750 0.5346 
2DAP 74.13 0.040 0.046 0.2750 0.5346 
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Figure 2.8. FTIR spectra of PEG, PPG, and PTMG polyureas with 15% HS content. 
 
Dynamic mechanical analysis was performed to assess degree of phase 
separation of candidate polyureas, Figure 2.9. It was observed that PEG based polyureas 
had a broad Tg ranging from -40 ºC to 10 ºC, followed by a Tm at 37 ºC. PTMG and 
PPG based polyureas were found to have a sharp Tg at -55 ºC and -45 ºC, respectively. 
PTMG exhibited a Tm at 85 ºC, whereas PPG had no visible Tm within this range. The 
broad Tg of PEG based polyureas indicated possible phase mixing which correlates with 
the hydrogen bonding between the hard and soft segment seen in FTIR. The presence of 
a Tm at 37 °C in PEG polyureas indicates decreased mobility of the soft segment at 
room temperature, explaining plastic deformation as well as the need to cast films at 
elevated temperatures. PTMG based polyureas showed increased phase separation when 
compared to PEG polyureas, which is attributed to the reduction in hydrogen bonding 
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between the hard and soft segment and increased thermodynamic incompatibility 
between the more hydrophobic polymer and the polar hard segments.
210-212
 
 
 
Figure 2.9. Dynamic mechanical analysis of PEG, PPG, and PTMG polyureas 
containing 15% HS content. 
 
Stress strain plots were analyzed to investigate the impact of soft segment 
chemistry and the observed differences in morphology on tensile properties, Figure 
2.10. PEG, PPG, and PTMG polyureas all displayed yield point, followed by drawing in 
PTMG and PEG based polyureas as discussed previously. PEG polyureas were 
characterized by a 2% secant modulus of 52.2 MPa ± 4.3 MPa, an ultimate elongation 
before failure of 1130% ± 20%, and an ultimate tensile strength of 25.4 MPa ± 4.9 MPa. 
PPG polyureas were characterized by a 2% secant modulus of 36.3 MPa ± 8.1 MPa, an 
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ultimate elongation before failure of 100% ± 10%, and an ultimate tensile strength of 5.4 
MPa ± 1.1 MPa. PTMG polyureas were characterized by a 2% secant modulus of 87.6 
MPa ± 9.1 MPa, an ultimate elongation before failure of 650% ± 60%, and an ultimate 
tensile strength of 17.1 MPa ± 6.7 MPa, Figure 2.10. Mechanical properties as well as 
molecular weight values are provided, Table 2.5. The high modulus and strength seen in 
PEG polyureas is attributed to its semicrystallinity discussed previously. PPG polyureas 
perform similarly, but break early around 100%. PPG’s poor tensile strength is attributed 
to its low molecular weight relative to PTMG and PEG based polyureas, Figure 2.11. 
This has been attributed to its hydrophobicity causing premature phase separation and 
poor compositional homogeneity.
210
 Low tensile strength for comparatively similar PPG 
based polyuretheanes is also well documented to be a result of the soft segment’s 
inability to crystallize under strain.
210,213
 While PEG based polyureas exhibit superior 
mechanical strength, they have poor recovery after failure, indicating the crystalline 
domains have undergone plastic deformation.  
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 Figure 2.10. Stress-strain plots of PEG, PPG, and PTMG polyureas containing 15% HS 
content. 
  
Table 2.5. Mechanical properties of PEG, PPG, and PTMG polyureas containing 15% HS 
content. 
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Polyurea 
Modulus 
(MPa) 
Strength 
(MPa) 
Elongation 
(%) 
Permanent 
Set (%) 
Mw 
(kDa) 
Polydispersity 
(Mw/Mn) 
PU-PEG 52.2 ± 4.3 25.4 ± 4.9 1130 ± 20 352 ± 23 
210 ± 
13 
2.61 ± 0.10 
PU-PPG 36.3 ± 8.1 5.4 ± 1.1 100 ± 3 10 ± 3 72 ± 7 2.40 ± 0.21 
PU-PTMG 87.6 ± 9.1 17.1 ± 6.7 650 ± 60 112 ± 8 
231 ± 
15 
2.35 ± 0.14 
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Figure 2.11 Molecular weight analysis of GPC PEG, PPG, and PTMG polyureas 
 
2.5 Conclusions 
PEG based polyurea formulations using EDA as the chain extender with HS 
content ranging from 10-14% were successfully synthesized and characterized. It was 
found that HS content displayed a positive correlation with modulus, elongation, and  
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tensile strength. Formulations with 14% HS was the maximum level achieved without 
gelation. Chain extender combinations of EDA and BDA, EDA and 3DAP, and 3DAP 
and 2DAP, were used to alter hard segment registry and modulate hydrogen bonding 
such that 15% HS polyureas could be synthesized without gelation. Polyurea 
formulations with different soft segment chemistries, PEG, PPG and PTMG, were 
synthesized and characterized to analyze the effect on morphology and mechanical 
properties. It was found that PPG based polyureas had very poor mechanical modulus, 
strength, and elongation and were thus inadequate as a candidate scaffold. PEG based 
polyureas had the highest tensile strength and elongation but poor elasticity. Notably, 
PEG-based polyureas swelled significantly in water with a dramatic loss of mechanical 
properties. PTMG based polyureas had tensile strengths beyond the target 10 MPa 
requirement as a ligament scaffold and did not absorb water in any significant amount. 
This formulation was selected for subsequent biodegradable polyurea testing. 
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CHAPTER III 
BIODEGRADABLE POLYUREAS 
3.1 Introduction 
The majority of biodegradable, synthetic polymers used in tissue engineering 
scaffolds incorporate ester or anhydride linkages that degrade via hydrolysis. Success of 
ligament grafts depends upon (1) the construct retaining sufficient mechanical properties 
to stabilize the joint throughout remodeling; (2) the new tissue receiving the appropriate 
level of load for directed collagenous organization/alignment. It continues to be difficult 
to both predict and tailor the non-specific hydrolysis of current synthetic biomaterials; 
whereas, natural materials are limited by mass-production, variability, or lack the tensile 
properties necessary for ligament applications. Therefore, new biomaterials are needed 
that can meet the complex design criteria necessary for ligament repair.   
Collagen-mimetic polyureas have the potential to combine the strength and 
tunability of synthetic elastomers with the cell-responsive degradation of native 
collagen. System-responsive degradation of a collagen-mimetic peptide isolated to the 
soft segment would integrate polyurea biodegradation with native ligament remodeling. 
By yielding control of scaffold degradation to the cell, the scaffold will degrade at a rate 
that best promotes tissue formation and organization. To this end, the MMP-2 sensitive 
peptide, GPQGIWGQGK, was identified as an efficient route for cell-responsive 
scaffold degradation
214
. Proteolytically degradable peptides such as this have been used 
in tissue engineering scaffold such as hydrogels, but have not yet been utilized in load 
bearing scaffold such as elastomers
215
. We hypothesize that incorporation of this 
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collagen oligopeptide into the soft segment of the polyurea elastomer will decouple the 
degradation rate and mechanical properties of these new biomimetic polymers. 
For this portion of the study, a polyurea elastomer was synthesized that 
incorporates the selected collagen-derived peptide into the backbone of the polymer 
chain, Figure 3.1. A triblock soft segment structure was designed with PTMG on the 
two ends and a short PEG linker unit in the center that to serve as an analog for the 
peptide. For biodegradable formulations, a percentage of this PEG linker is substituted 
for the peptide which is approximately equivalent in molecular weight and similar in 
hydrophilicity. This is expected to result in minimal changes to the phase separated 
morphology and corollary mechanical properties of the polyurea. To test this hypothesis, 
polyureas with varying levels of peptide were characterized to determine the effect of 
the peptide on morphology, mechanical properties, and rate of enzymatic degradation. 
 
 
Figure 3.1. Cell responsive degradation mechanism in biodegradable polyureas 
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3.2 Materials 
Polyether diamines were acquired from Huntsman Corporation. PEG based 
polyether diamine, (RE-900, Mn=900 Da), and PTMG diamine, (XTJ-548, Mn=1700) 
were used. Polymers were azeotropically dried by dissolving in Toluene at a 
concentration of 100 mg/mL, and then removed by rotary evaporation at 100ºC. Hexane 
diisocyanate HDI, ethylene diamine (EDA), 1,2-diaminopropane (2DAP), 1,3-
diaminopropane (3DAP), and lithium bromide (LiBr) were obtained from Sigma Aldrich 
and used as received. Anhydrous dimethylformamide (DMF) was obtained from Sigma 
Aldrich, and stored over molecular sieves. PBS and Pen-Strep solution (10,000 meq/mL, 
10 mg/mL) were obtained from Sigma Aldrich and used as received. Collagenase type 4 
was obtained from Worthington Biochemical Corporation Lakewood, NJ and used as 
received. 
 
3.3 Methods 
Biodegradable polyureas were synthesized in a manner similar to the biostable 
formulations. Polyureas had 15% HS content, composed of a 1:1 mixture of 2DAP and 
3DAP, in order to maximize mechanical properties while reducing the potential for 
gelation. PTMG based soft segments were selected because of their mechanical strength, 
hydrophobicity, and elasticity. The reaction scheme was modified in order to incorporate  
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the PEG oligomer. For biodegradable formulations, 10% or 20% of this PEG oligomer 
was substituted for the peptide. HS content was calculated from the HDI and diamines 
located in the HS blocks; this did not include HDI linking soft segment blocks. A table 
of reagents is provided, Table 3.1. 
Fourier transform infrared (FTIR) spectroscopic analysis was performed on a 
Bruker TENSOR 27 spectrometer to confirm reaction completion, extent of hydrogen 
bonding, and incorporation of the peptide. Reacted polymer solutions were cast onto 
glass petri dishes at 50 °C under partial, increasing vacuum (under a nitrogen blanket, 
starting at -200 mbar relative to atmosphere, decreasing 200 mbar every 6 hours, 
followed by full vacuum at 0 mbar for 24 hours) to a thickness of approximately 0.2 mm 
for tensile testing with an Instron 3345 Single Column Universal Testing System 
equipped with a 1 kN load cell and 250 N pneumatic grips, tested at 100% strain/minute. 
Dynamic mechanical analysis (DMA) was performed using a TA Instruments RSA3 
instrument to investigate relative phase separation. Temperature sweep tests were 
performed from -90ºC to 150ºC with a heating rate of 5ºC/min with a 200 g load cell. 
Polymer films were subjected to enzymatic degradation for up to 4 weeks and then 
examined for chemical, mechanical, and visual changes, (n=3). Specimens were 
submerged in 37 °C PBS solution with or without collagenase (10 mg/mL). All solutions 
contained 1% Pen-Strep solution to prevent microbial contamination. Solutions were 
changed and specimens were weighed weekly. Uniaxial tensile testing of samples took 
place 2 weeks and 4 weeks and were compared to control specimens. Scanning electron 
microscopy (SEM) was used to inspect polyurea films for surface damage. 
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Table 3.1. Reactants in PTMG based polyureas containing 15% HS content and 0%, 
10%, and 20% peptide content. 
PU-0PEP 
Molecular 
Weight (kDa) 
Grams mL 
molar 
ratio 
mmols 
PTMG Diamine 1700 3.500 3.500 1.0000 2.0588 
HDI (total) 168.2 0.984 0.940 2.8410 5.8491 
PEG(900)NH2 900 0.926 0.926 0.500 1.0294 
Peptide 1026 0.000 0.000 0.000 0 
3DAP 74.12 0.102 
 
0.6705 1.3804 
2DAP 74.13 0.102 0.118 0.6705 1.3804 
      
PU-10PEP 
Molecular 
Weight (kDa) 
Grams mL 
molar 
ratio 
mmols 
PTMG Diamine 1700 3.500 3.500 1.0000 2.0588 
HDI (total) 168.2 0.984 0.940 2.8410 5.8491 
PEG(900)NH2 900 0.834 0.834 0.450 0.9265 
Peptide 1026 0.106 0.106 0.050 0.1029 
3DAP 74.12 0.102 0.115 0.6705 1.3804 
2DAP 74.13 0.102 0.118 0.6705 1.3804 
      
PU-20PEP 
Molecular 
Weight (kDa) 
Grams mL 
molar 
ratio 
mmols 
PTMG Diamine 1700 3.500 3.500 1.0000 2.0588 
HDI (total) 168.2 0.984 0.940 2.8410 5.8491 
PEG(900)NH2 900 0.741 7.412 0.400 0.8235 
Peptide 1026 0.211 0.211 0.100 0.2059 
3DAP 74.12 0.102 0.115 0.6705 1.3804 
2DAP 74.13 0.102 0.118 0.6705 1.3804 
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Figure 3.2. Synthetic design of cell-responsive, biodegradable polyureas. 
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3.4 Results and Discussion 
3.4.1 Effect of Peptide on Morphology and Mechanical Properties 
FTIR spectra of polymer films contained peaks correlating to hydrogen bonded 
N-H stretching (3300 cm
-1
), the methyl backbone of PTMG and PEG (2900 cm
-1
), amide 
from the peptide, (C=O, 1660 cm
-1
, various intensities), urea (1650 cm
-1
), hydrogen 
bonded urea (1617 cm
-1
), and the ether backbone of PTMG and PEG (1080 cm
-1
), 
Figure 3.3. Although the peptide peak is convoluted by the urea peak, a trend was 
observed that indicated successful peptide incorporation. A shoulder at 1660 cm
-1
 
assigned to the amide of the peptide can be seen to increase with increaing peptide 
content. Additionally, subtracting the 0% peptide as a baseline, intensities at 1660 cm
-1
 
are observed to be at relative ratios of 1:1.76 for 10% and 20% peptide content, 
respectively. The presence of HB urea suggests that the peptide did not disrupt the two 
phase morphology. 
DMA plots of polyureas with varying peptide content are compared in Figure 
3.4. A broadening of the glass transition (Tg) with increasing peptide content was 
observed and was attributed to an increase in phase mixing. Given that the peptide 
contains many amide groups which function as hydrogen bond donors (N-H) and 
acceptors (C=O), it was hypothesized that the peptide provided an increased opportunity 
for hydrogen bonding between the hard and soft segments. 
 
 56 
 
  
 
Figure 3.3 FTIR spectra of PTMG based polyureas containing 15% HS content and 0%, 
10%, or 20% peptide content. 
 
Figure 3.4 Dynamic mechanical analysis of PTMG polyureas with 15% HS content and 
0%, 10%, or 20% peptide content. 
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Stress strain plots were analyzed to investigate the impact of the peptide and its 
observed differences in morphology on tensile properties, Figure 3.5. PTMG polyureas 
all displayed a yield point, followed by drawing as discussed previously. Polyureas with 
0% peptide were characterized by a 2% secant modulus of 25.3 MPa ± 0.8 MPa, an 
ultimate elongation before failure 310% ± 20%, and an ultimate tensile strength of 7.2 
MPa ± 0.2 MPa. Polyureas with 10% peptide were characterized by a 2% secant 
modulus of 43.0 MPa ± 2.9 MPa, an ultimate elongation before failure of 390% ± 10%, 
and an ultimate tensile strength of 7.6 MPa ± 0.4 MPa. Polyureas with 20% peptide were 
characterized by a 2% secant modulus of 45.4 MPa ± 1.3 MPa, an ultimate elongation 
before failure of 510% ± 10%, and an ultimate tensile strength of 10.8 MPa ± 0.3 MPa, 
Figure 3.5. A table of mechanical properties is provided, Table 3.2. Overall, tensile 
properties of polyureas with varying peptide content showed increased tensile strength 
and elongation with increasing peptide content, Figure 3.5. The increase in phase 
mixing evident in the DMA with increasing peptide content was hypothesized to have 
been a result of the peptide hydrogen bonding with the hard segment. This increased 
phase mixing permitted continued chain organization and strain induced crystallization, 
resulting in increased ultimate tensile strength.  
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Figure 3.5 Stress-strain behavior of PTMG based polyureas containing 15% HS content 
and 0%, 10%, or 20% peptide content. 
 
Table 3.2. Tensile properties of untreated polyureas. 
  Modulus (MPa) Elongation (%) Strength (MPa) 
PU-0PEP 25.3 ± 0.8 310 ± 20 7.2 ± 0.2 
PU-10PEP 43 ± 2.9 390 ± 10 7.6 ± 0.4 
PU-20PEP 45.4 ± 1.3 510 ± 10 10.8 ± 0.3 
 
 
3.4.2 Enzymatic Degradation of Biodegradable Polyureas 
Polymer films were subjected to degradation in collagenase solutions over 4 
weeks. Fourier transform infrared (FTIR) spectroscopic analysis was used to evaluate 
peptide degradation, Figure 3.6. A detailed view of the carbonyl region of the polyureas 
is also provided, Figure 3.7. No evidence of degradation was observed for control 
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specimens, as expected. A decrease in peak height at 1660 cm
-1
 assigned to the peptide 
was observed after 4 weeks of degradation in polyureas with 20% peptide content; 
however, no corollary decrease was discernible in polyureas with 10% peptide content. 
Subtracting the 0% peptide as a baseline, polyureas with 20% peptide content 
experienced a 40% reduction in the peak at 1660 cm
-1
 indicating possible chain scission 
of the peptide and extraction of low molecular weight species. No spectral changes were 
detected in polyureas with 10% or 20% peptide when subject to degradation in PBS 
without collagenase. This indicates that the changes were specific to enzymatic chain 
scission. 
 
Figure 3.6 FTIR analysis of PTMG based polyureas containing 15% HS content and 
0%, 10%, and 20% peptide content after 4 weeks of degradation in PBS/collagenase. 
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Figure 3.7 FTIR analysis of PTMG based polyureas containing 15% HS content and 0%, 
10%, and 20% peptide content after 4 weeks of degradation in PBS/collagenase (carbonyl 
region). 
 
Stress strain plots of specimens subjected to 4 weeks of degradation were 
analyzed to investigate the impact of degradation on tensile properties, Figure 3.8, 3.9, 
3.10. Polyureas displayed a yield point, followed by drawing and in some instances a 
degree of strain induced crystallization. A complete table of values obtained from the 
degradation study is included, Table 3.3. This table features modulus, elongation, and 
strength for polyureas with 0%, 10%, and 20% peptide. Values are given for control, 2 
weeks, and 4 weeks, for PBS and collagenase solutions. For polyureas with 0% peptide 
content, there is no significant change in modulus, elongation, or strength when subject 
to degradation in PBS or collagenase when compared with untreated samples. For 
polyureas with 10% peptide content, a small decrease in tensile strength and elongation 
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was observed at 4 weeks in collagenase, but this difference was not statistically 
significant. For polyureas with 20% peptide content, a statistically significant decrease 
in tensile strength and elongation was observed at 2 and 4 weeks. It is important to note 
that this difference was only present in films subjected to degradation in collagenase, not 
PBS alone. No statistically significant changes were seen in modulus, or in any samples 
in subject to degradation in PBS at 2 weeks or 4 weeks compared to untreated samples. 
Percent change of modulus, elongation and strength are displayed in Figures 
3.11, 3.12, 3.13. These results correlate well with the infrared findings that indicate 
cleavage of the peptide. Peptide degradation results in lower molecular weight, 
correlating to lower ultimate tensile strength, as discussed previously. Reduction in 
ultimate elongation is explicated by peptide degradation as well. Overall, the reduction 
in mechanical properties was attributed to peptide cleavage shown in FTIR analysis. 
 
Figure 3.8 Stress-strain behavior of polyureas with 0% peptide content after 4 weeks of 
degradation in PBS/collagenase compared to untreated samples. 
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Figure 3.9 Stress-strain behavior of polyureas with 10% peptide content after 4 weeks of 
degradation in PBS/collagenase compared to untreated samples. 
 
 
Figure 3.10 Stress-strain behavior of polyureas with 20% peptide content after 4 weeks 
of degradation in PBS/collagenase compared to untreated samples. 
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Figure 3.11 Percent change in ultimate tensile strength of specimens after 2 and 4 
weeks of degradation in PBS or PBS/collagenase solution. 
 
 
Figure 3.12 Percent change in ultimate elongation of specimens after 2 and 4 
weeks of degradation in PBS or PBS/collagenase solution. 
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Figure 3.13 Percent change in initial (2% secant) modulus of specimens after 2 
and 4 weeks of degradation in PBS or PBS/collagenase solution. 
 
 
Table 3.3 Tensile properties of polyureas after 2 and 4 weeks of degradation in PBS or 
PBS/collagenase solution. 
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PU-10PEP 43 ± 2.9 43.3 ± 1.3 43.4 ± 4.6 56.5 ± 5.1 57 ± 5.9 
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Strength Control  
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PBS 
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PBS 
2 weeks in 
Collagenase 
4 weeks in 
Collagenase 
PU-0PEP 7.2 ± 0.2 7.2 ± 0.2 7.4 ± 0.3 7 ± 0.3 7.6 ± 0.1 
PU-10PEP 7.6 ± 0.4 7.5 ± 0.4 8.1 ± 0.4 6.1 ± 0.5 5.7 ± 0.2 
PU-20PEP 10.8 ± 0.3 11.4 ± 0.1 11 ± 0.7 8.6 ± 0.3 7.8 ± 0.2 
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SEM was used to analyze the surface of degraded and control polymer films, 
Figure 3.14. Polyurea specimens with 0% peptide films were found to a very smooth 
topography, with no visible difference between the untreated and samples aged in 
collagenase for 4 weeks. The 20% peptide films were observed to have a smooth surface 
before degradation, but show a rough, patterned surface after being subject to 
degradation in collagenase solution for 4 weeks. The surface roughness is likely due to 
surface degradation. Enzymatic degradation is expected to be localized to the surface 
because enzymes are typically too large to diffuse into the polymer and cause bulk 
degradation.
132,216,217
 The observed surface degradation is concordant with changes in 
chemical and tensile properties. The bond cleavage and reduction in strength support a 
possible reduction in molecular weight; however, due to the extent of hydrogen bonding, 
films could not be dissolved for molecular weight analysis with GPC. Despite the 
evidence of surface degradation, no significant mass loss was observed at these time 
points. 
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Figure 3.14 SEM images of polyurea film surface damage after 4 weeks of degradation 
in PBS solution with collagenase. 
 
 
3.5 Conclusions 
In summary, we have characterized the physical properties of a novel 
biodegradable polyurea and subjected it to enzymatic degradation. Infrared spectral 
analysis confirmed the presence of both HB urea and amide bonds in approximate 
proportion with their peptide content. A broadening of Tg indicative of phase mixing 
was observed with increased peptide content, accompanied by increased elongation and 
strength. This phase mixing was attributed to increased hydrogen bonding between the 
soft and hard segment due to the presence of amide bonds in the peptide. 
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FITR spectral analysis indicated a reduction in amide (1660cm
-1
) bonds 
correlating to the enzyme-labile peptide in samples with 20% peptide content that were 
subjected to enzymatic degradation. This was accompanied by a statistically significant 
reduction in strength. These changes were not observed in specimens incubated in buffer 
alone or control polyureas which indicates that the observed changes were due to 
enzymatic degradation. In summary, the results of the current study indicate successful 
synthesis of polyureas with cell-responsive degradation. Further elucidation of key 
structure-property relationships is necessary to determine the effect of composition on 
microphase-separated morphology. Ultimately, understanding such relationships will be 
critical for the development of an improved tissue engineered ligament for ACL 
reconstruction. 
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CHAPTER   IV 
SUMMARY 
 In this study, a library of polyureas was developed to elucidate key structure 
property relationships for the development of a tissue engineered ligament. Polyurea 
formulations were optimized by investigating the effect of increased hard segment 
content, chain extender chemistry, and soft segment chemistry. Increases in hard 
segment content were shown to increase tensile modulus, elongation, and strength. 
However, due to the intensity of hydrogen bonding in polyureas, hard segment content 
could not be increased above 15% before the polymer solution would form a gel, 
resulting in an unprocessable polymer solution. Chain extender combinations were 
formulated to alter the registry of the hard segment, incrementally modifying the degree 
of hydrogen bonding in order to prevent gelation. Polyureas were formulated to test 
mixed length (EDA and BDA), mixed symmetry (EDA and 3DAP), and a combination 
of mixed length, symmetry, and sterically-hindering groups (2DAP and 3DAP) 
compared to polyureas utilizing EDA alone. Chain extenders with mixed length (EDA 
and BDA) and mixed symmetry (EDA and 3DAP) both successfully decreased HB urea 
at 1617cm
-1
 compared to polyureas made with EDA. A mixture of chain extenders with 
different length, symmetry, and sterically-hindering groups (2DAP and 3DAP) proved to 
be the most successful at reducing HB urea. Only formulations with this chain extender 
combination did not gel and were able to be cast into films for tensile testing.  
Polyureas with PEG, PPG and PTMG soft segments were then synthesized to 
analyze the effect of soft segment chemistry on phase separation, chemical, and 
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mechanical properties. PPG polyureas were found to be mechanically weak and 
unsuitable for tensile load bearing applications, likely due to low molecular weight 
formation due to early precipitation during synthesis. PEG based polyureas had high 
tensile strength, but poor elasticity. It was also noted that PEG polyureas swelled in 
water and became mechanically weak. PTMG based polyureas had tensile strengths 
beyond the target value of 10 MPa and had low water uptake values. This formulation 
was selected for subsequent biodegradable polyurea testing.  
A triblock structure for biodegradable polyureas was utilized to localize the 
peptide to the backbone of the soft segment. PTMG diamine was reacted with HDI to 
form diisocyanate functional PTMG. PTMG diisocyanate was then reacted with a 
shorter PEG diamine oligomer, endcapping it with PTMG, resulting in a diisocyanate 
functional PTMG-PEG-PTMG triblock structure. For biodegradable formulations, a 
portion of the PEG linker was substituted for the peptide. The optimized chain extender 
mixture was then added to build molecular weight. The presence of strong IR peaks 
assigned to hydrogen-bonded hard segments confirmed phase-separated morphology; 
however, overlapping of carbonyl peaks in the spectra of all peptide-based systems 
made quantification of peptide content difficult. Dynamic mechanical analysis 
confirmed a phase separated morphology and the inclusion of the peptide increased 
phase mixing. Tensile testing of biodegradable polyureas indicated increased elongation, 
strength, and initial modulus correlating to possible interaction between the hard and 
soft segment caused by the peptide.  
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Biodegradable polyurea formulations were then cast into films and subjected to 
degradation testing in PBS solution with and without collagenase for 4 weeks. Samples 
were characterized with uniaxial tensile testing and stress-strain plots were examined to 
determine the effects of degradation on mechanical properties. Statistically significant 
changes in strength and elongation of polyureas with 20% peptide content were 
observed for samples in collagenase solutions only. Samples subjected to degradation in 
PBS only saw no significant changes in mechanical properties. SEM micrographs 
displayed surface damage on polyureas with 20% peptide content which were subjected 
to degradation in collagenase. No observable change was noticed in control polyureas 
and biodegradable polyureas in PBS solution alone. 
Overall, these polyureas combine the strength and tunability of synthetic 
elastomers with the cell-responsive degradation of native collagen. This hybrid design 
integrates the graft into native ligament remodeling and may facilitate load transfer from 
the biodegradable scaffold to neotissue at a rate that promotes proper tissue orientation 
and function while maintaining construct integrity. The addition of cell-responsive 
degradation to one of the most versatile classes of biomaterials makes these hybrid 
grafts  
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promising. In addition to the development of an improved biomaterial for ACL 
reconstruction, synthetic strategies used to generate a library of cell-responsive, 
biodegradable polyureas can be utilized for a variety of other biomedical applications as 
well. Similar to the current approach, enzyme-labile polyureas can be developed to 
create new structure-property models for bone or cardiovascular tissue engineering. A 
polymeric system that combines the tunability of segmented block copolymers with 
system-responsive degradation can also be used to achieve effective drug delivery.
218,219
 
Based on the versatility of the synthetic routes described above, enzyme-labile peptide 
sequences can be replaced with other sequences to produce an assortment of biomimetic 
materials. Overall, the synthesis of a library of cell-responsive, biodegradable polyureas 
will assist in the development of a tissue engineered ligament, as well as provide 
additional tools to advance biomaterial design. 
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